全部 标题 作者
关键词 摘要

Nutrients  2013 

Dietary Omega-3 Fatty Acid Deficiency and High Fructose Intake in the Development of Metabolic Syndrome, Brain Metabolic Abnormalities, and Non-Alcoholic Fatty Liver Disease

DOI: 10.3390/nu5082901

Keywords: metabolic syndrome and insulin resistance, dietary omega-3 fatty acid deficiency, high fructose intake, non-alcoholic fatty liver disease, brain insulin resistance, hippocampus, learning, memory, appetite, inflammation, endocannabinoids, neurodegenerative diseases

Full-Text   Cite this paper   Add to My Lib


Western diets are characterized by both dietary omega-3 fatty acid deficiency and increased fructose intake. The latter found in high amounts in added sugars such as sucrose and high fructose corn syrup (HFCS). Both a low intake of omega-3 fatty acids or a high fructose intake contribute to metabolic syndrome, liver steatosis or non-alcoholic fatty liver disease (NAFLD), promote brain insulin resistance, and increase the vulnerability to cognitive dysfunction. Insulin resistance is the core perturbation of metabolic syndrome. Multiple cognitive domains are affected by metabolic syndrome in adults and in obese adolescents, with volume losses in the hippocampus and frontal lobe, affecting executive function. Fish oil supplementation maintains proper insulin signaling in the brain, ameliorates NAFLD and decreases the risk to metabolic syndrome suggesting that adequate levels of omega-3 fatty acids in the diet can cope with the metabolic challenges imposed by high fructose intake in Western diets which is of major public health importance. This review presents the current status of the mechanisms involved in the development of the metabolic syndrome, brain insulin resistance, and NAFLD a most promising area of research in Nutrition for the prevention of these conditions, chronic diseases, and improvement of Public Health.


[1]  Simopoulos, A.P. The importance of the omega-6/omega-3 Fatty Acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood) 2008, 233, 674–688, doi:10.3181/0711-MR-311.
[2]  Johnson, R.K.; Appel, L.J.; Brands, M.; Howard, B.V.; Lefevre, M.; Lustig, R.H.; Sacks, F.; Steffen, L.M.; Wylie-Rosett, J. American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism and the Council on Epidemiology and Prevention. Dietary sugars intake and cardiovascular health: A scientific statement from the American Heart Association. Circulation. 2009, 120, 1011–1020.
[3]  Simopoulos, A.P. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 1991, 54, 438–463.
[4]  Stanhope, K.L.; Schwarz, J.M.; Keim, N.L.; Griffen, S.C.; Bremer, A.A.; Graham, J.L.; Hatcher, B.; Cox, C.L.; Dyachenko, A.; Zhang, W.; et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 2009, 119, 1322–1334, doi:10.1172/JCI37385.
[5]  Fung, T.T.; Malik, V.; Rexrode, K.M.; Manson, J.E.; Willett, W.C.; Hu, F.B. Sweetened beverage consumption and risk of coronary heart disease in women. Am. J. Clin. Nutr. 2009, 89, 1037–1042, doi:10.3945/ajcn.2008.27140.
[6]  Montonen, J.; J?rvinen, R.; Knekt, P.; Heli?vaara, M.; Reunanen, A. Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J. Nutr. 2007, 137, 1447–1454.
[7]  Blasbalg, T.L.; Hibbeln, J.R.; Ramsden, C.E.; Majchrzak, S.F.; Rawlings, R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93, 950–962, doi:10.3945/ajcn.110.006643.
[8]  Storlien, L.H.; Jenkins, A.B.; Chisholm, D.J.; Pascoe, W.S.; Khouri, S.; Kraegen, E.W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991, 40, 280–289.
[9]  Borkman, M.; Storlien, L.H.; Pan, D.A.; Jenkins, A.B.; Chisholm, D.J.; Campbell, L.V. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 1993, 328, 238–244, doi:10.1056/NEJM199301283280404.
[10]  Farooqui, A.A.; Farooqui, T.; Panza, F.; Frisardi, V. Metabolic syndrome as a risk factor for neurological disorders. Cell Mol. Life Sci. 2012, 69, 741–762, doi:10.1007/s00018-011-0840-1.
[11]  Yates, K.F.; Sweat, V.; Yau, P.L.; Turchiano, M.M.; Convit, A. Impact of metabolic syndrome on cognition and brain: A selected review of the literature. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2060–2067, doi:10.1161/ATVBAHA.112.252759.
[12]  Williamson, R.; McNeilly, A.; Sutherland, C. Insulin resistance in the brain: An old-age or new-age problem? Biochem. Pharmacol. 2012, 84, 737–745, doi:10.1016/j.bcp.2012.05.007.
[13]  De La Monte, S.M. Metabolic derangements mediate cognitive impairment and Alzheimer’s disease: Role of peripheral insulin-resistance diseases. Panminerva Med. 2012, 54, 171–178.
[14]  González-Périz, A.; Horrillo, R.; Ferré, N.; Gronert, K.; Dong, B.; Morán-Salvador, E.; Titos, E.; Martínez-Clemente, M.; López-Parra, M.; Arroyo, V.; et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins. FASEB J. 2009, 23, 1946–1957, doi:10.1096/fj.08-125674.
[15]  Simopoulos, A.P. Evolutionary Aspects of Diet and Essential Fatty Acids. In Fatty Acids and Lipids—New Findings; Hamazaki, T., Okuyama, H., Eds.; Kagar: Basel, Switzerland, 2001; pp. 18–27.
[16]  Palmer, J.R.; Boggs, D.A.; Krishnan, S.; Hu, F.B.; Singer, M.; Rosenberg, L. Sugar sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch. Intern. Med. 2008, 168, 1487–1492, doi:10.1001/archinte.168.14.1487.
[17]  Schulze, M.B.; Manson, J.E.; Ludwig, D.S.; Colditz, G.A.; Stampfer, M.J.; Willett, W.C.; Hu, F.B. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004, 292, 927–934, doi:10.1001/jama.292.8.927.
[18]  Bremer, A.A.; Auinger, P.; Byrd, R.S. Sugar-sweetened beverage intake trends in U.S. adolescents and their association with insulin resistance-related parameters. J. Nutr. Metab. 2009, doi:10.1155/2010/196476.
[19]  Yoshida, M.; McKeown, N.M.; Rogers, G.; Meigs, J.B.; Saltzman, E.; D’Agostino, R.; Jacques, P.F. Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults. J. Nutr. 2007, 137, 2121–2127.
[20]  Aeberli, I.; Hochuli, M.; Gerber, P.A.; Sze, L.; Murer, S.B.; Tappy, L.; Spinas, G.A.; Berneis, K. Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: A randomized controlled trial. Diabetes Care 2013, 36, 150–156, doi:10.2337/dc12-0540.
[21]  Tappy, L.; Lê, K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 2010, 90, 23–46, doi:10.1152/physrev.00019.2009.
[22]  Tappy, L.; Mittendorfer, B. Fructose toxicity: Is the science ready for public health actions? Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 357–361, doi:10.1097/MCO.0b013e328354727e.
[23]  Lecoultre, V.; Egli, L.; Carrel, G.; Theytaz, F.; Kreis, R.; Schneiter, P.; Boss, A.; Zwygart, K.; Lê, K.A.; Bortolotti, M.; et al. Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity 2013, 21, 782–785, doi:10.1002/oby.20377.
[24]  Reaven, G.M. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988, 37, 1595–1607.
[25]  Foster, D.W. Insulin resistance—A secret killer? N. Engl. J. Med. 1989, 320, 733–734, doi:10.1056/NEJM198903163201111.
[26]  Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346, 1221–1231, doi:10.1056/NEJMra011775.
[27]  Sanyal, A.J. American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002, 123, 1705–1725, doi:10.1053/gast.2002.36572.
[28]  Ford, E.S.; Li, C.; Zhao, G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J. Diabetes 2010, 2, 180–193, doi:10.1111/j.1753-0407.2010.00078.x.
[29]  Ferrannini, E. Metabolic abnormalities of hypertension. A lesson in complexity. Hypertension 1991, 18, 636–639, doi:10.1161/01.HYP.18.5.636.
[30]  Simopoulos, A.P. Fatty acid composition of skeletal-muscle membrane phospholipids, insulin resistance and obesity. Nutr. Today 1994, 29, 12–16, doi:10.1097/00017285-199401000-00004.
[31]  Simopoulos, A.P. Is insulin resistance influenced by dietary linoleic acid and trans fatty acids? Free Radic. Biol. Med. 1994, 17, 367–372, doi:10.1016/0891-5849(94)90023-X.
[32]  Lauritzen, L.; Hansen, H.S.; Jorgensen, M.H.; Michaelsen, K.F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 2001, 40, 1–94, doi:10.1016/S0163-7827(00)00017-5.
[33]  Parker, G.; Gibson, N.A.; Brotchie, H.; Heruc, G.; Rees, A.M.; Hadzi-Pavlovic, D. Omega-3 fatty acids and mood disorders. Am. J. Psychiatry 2006, 163, 969–978, doi:10.1176/appi.ajp.163.6.969.
[34]  Di Marzo, V.; Goparaju, S.K.; Wang, L.; Liu, J.; Bátkai, S.; Járai, Z.; Fezza, F.; Miura, G.I.; Palmiter, R.D.; Sugiura, T.; et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410, 822–825, doi:10.1038/35071088.
[35]  Osei-Hyiaman, D.; DePetrillo, M.; Pacher, P.; Liu, J.; Radaeva, S.; Bátkai, S.; Harvey-White, J.; Mackie, K.; Offertáler, L.; Wang, L.; et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Investig. 2005, 115, 1298–1305.
[36]  Pagotto, U.; Marsicano, G.; Cota, D.; Lutz, B.; Pasquali, R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr. Rev. 2006, 27, 73–100.
[37]  Christensen, R.; Kristensen, P.K.; Bartels, E.M.; Bliddal, H.; Astrup, A. Efficacy and safety of the weight-loss drug rimonabant: A meta-analysis of randomised trials. Lancet 2007, 370, 1706–1713, doi:10.1016/S0140-6736(07)61721-8.
[38]  Samat, A.; Tomlinson, B.; Taheri, S.; Thomas, G.N. Rimonabant for the treatment of obesity. Recent Pat. Cardiovasc. Drug Discov. 2008, 3, 187–193.
[39]  Alvheim, A.R.; Malde, M.K.; Osei-Hyiaman, D.; Lin, Y.H.; Pawlosky, R.J.; Madsen, L.; Kristiansen, K.; Fr?yland, L.; Hibbeln, J.R. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity 2012, 20, 1984–1994, doi:10.1038/oby.2012.38.
[40]  Evans, D.L.; Charney, D.S.; Lewis, L.; Golden, R.N.; Gorman, J.M.; Krishnan, K.R.; Nemeroff, C.B.; Bremner, J.D.; Carney, R.M.; Coyne, J.C.; et al. Mood disorders in the medically ill: Scientific review and recommendations. Biol. Psychiatry 2005, 58, 175–189, doi:10.1016/j.biopsych.2005.05.001.
[41]  Lafourcade, M.; Larrieu, T.; Mato, S.; Duffaud, A.; Sepers, M.; Matias, I.; de Smedt-Peyrusse, V.; Labrousse, V.F.; Bretillon, L.; Matute, C.; et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 2011, 14, 345–350, doi:10.1038/nn.2736.
[42]  World Health Organization. Diet, Nutrition and the Prevention of Chronic Diseases. Report of the Joint WHO/FAO Expert Consultation; WHO: Geneva, Switzerland, 2003.
[43]  Parks, E.J.; Hellerstein, M.K. Carbohydrate-induced hypertriacylglycerolemia: Historical perspective and review of biological mechanisms. Am. J. Clin. Nutr. 2000, 71, 412–433.
[44]  Schwarz, J.M.; Neese, R.A.; Turner, S.; Dare, D.; Hellerstein, M.K. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and wholebody fuel selection. J. Clin. Investig. 1995, 96, 2735–2743.
[45]  Sevastianova, K.; Santos, A.; Kotronen, A.; Hakkarainen, A.; Makkonen, J.; Silander, K.; Peltonen, M.; Romeo, S.; Lundbom, J.; Lundbom, N.; et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am. J. Clin. Nutr. 2012, 96, 727–734, doi:10.3945/ajcn.112.038695.
[46]  Stanhope, K.L.; Bremer, A.A.; Medici, V.; Nakajima, K.; Ito, Y.; Nakano, T.; Chen, G.; Fong, T.H.; Lee, V.; Menorca, R.I.; et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J. Clin. Endocrinol. Metab. 2011, 96, E1596–E1605, doi:10.1210/jc.2011-1251.
[47]  Ruxton, C.H.; Gardner, E.J.; McNulty, H.M. Is sugar consumption detrimental to health? A review of the evidence 1995–2006. Crit. Rev. Food Sci. Nutr. 2010, 50, 1–19, doi:10.1080/10408398.2010.526825.
[48]  Dolan, L.C.; Potter, S.M.; Burdock, G.A. Evidence-based review on the effect of normal dietary consumption of fructose on development of hyperlipidemia and obesity in healthy, normal weight individuals. Crit. Rev. Food Sci. Nutr. 2010, 50, 53–84.
[49]  Dolan, L.C.; Potter, S.M.; Burdock, G.A. Evidence-based review on the effect of normal dietary consumption of fructose on blood lipids and body weight of overweight and obese individuals. Crit. Rev. Food Sci. Nutr. 2010, 50, 889–918, doi:10.1080/10408398.2010.512990.
[50]  Stanhope, K.L.; Griffen, S.C.; Bremer, A.A.; Vink, R.G.; Schaefer, E.J.; Nakajima, K.; Schwarz, J.M.; Beysen, C.; Berglund, L.; Keim, N.L.; et al. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Am. J. Clin. Nutr. 2011, 94, 112–119, doi:10.3945/ajcn.110.002246.
[51]  Ding, E.L.; Malik, V.S. Convergence of obesity and high glycemic diet on compounding diabetes and cardiovascular risks in modernizing China: An emerging public health dilemma. Glob. Health 2008, 4, 4, doi:10.1186/1744-8603-4-4.
[52]  Hu, F.B.; Malik, V.S. Sugar-sweetened beverages and risk of obesity and type 2 diabetes: Epidemiologic evidence. Physiol. Behav. 2010, 100, 47–54, doi:10.1016/j.physbeh.2010.01.036.
[53]  Schernhammer, E.S.; Hu, F.B.; Giovannucci, E.; Michaud, D.S.; Colditz, G.A.; Stampfer, M.J.; Fuchs, C.S. Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 2098–2105, doi:10.1158/1055-9965.EPI-05-0059.
[54]  Lê, K.A.; Faeh, D.; Stettler, R.; Ith, M.; Kreis, R.; Vermathen, P.; Boesch, C.; Ravussin, E.; Tappy, L. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am. J. Clin. Nutr. 2006, 84, 1374–1379.
[55]  Silbernagel, G.; Machann, J.; Unmuth, S.; Schick, F.; Stefan, N.; H?ring, H.U.; Fritsche, A. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: An exploratory trial. Br. J. Nutr. 2011, 106, 79–86, doi:10.1017/S000711451000574X.
[56]  USDA database for the added sugars content of selected foods. February 2006. Available online: http://www.nal.usda.gov/fnic/foodcamp/Data/add_sug/addsug01.pdf (accessed on 15 February 2013).
[57]  Smart Choices Program: Guiding Food Choices. Smart Choices Program Web site, Available online: http://smartchoicesprogram.com (accessed on 15 February 2013).
[58]  Guiding Stars Program. Hannaford Brothers Co Web site, Available online: http://www.hannaford.com/Contents/Healthy_Living/Guiding_Stars/index.shtml (accessed on 15 February 2013).
[59]  NuVal Nutritional Scoring System. Available online: http://www.nuval.com (accessed on 15 February 2013).
[60]  Drewnowski, A. Concept of a nutritious food: Toward a nutrient density score. Am. J. Clin. Nutr. 2005, 82, 721–732.
[61]  Nguyen, S.; Choi, H.K.; Lustig, R.H.; Hsu, C.Y. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J. Pediatr. 2009, 154, 807–813, doi:10.1016/j.jpeds.2009.01.015.
[62]  Fried, S.K.; Rao, S.P. Sugars, hypertriglyceridemia, and cardiovascular disease. Am. J. Clin. Nutr. 2003, 78, 873S–880S.
[63]  Parks, E.J.; Skokan, L.E.; Timlin, M.T.; Dingfelder, C.S. Dietary sugars stimulate fatty acid synthesis in adults. J. Nutr. 2008, 138, 1039–1046.
[64]  Chong, M.F.; Fielding, B.A.; Frayn, K.N. Mechanisms for the acute effect of fructose on postprandial lipemia. Am. J. Clin. Nutr. 2007, 85, 1511–1520.
[65]  Ceriello, A.; Bortolotti, N.; Crescentini, A.; Motz, E.; Lizzio, S.; Russo, A.; Ezsol, Z.; Tonutti, L.; Taboga, C. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Eur. J. Clin. Investig. 1998, 28, 329–333, doi:10.1046/j.1365-2362.1998.00295.x.
[66]  Ma, S.W.; Tomlinson, B.; Benzie, I.F. A study of the effect of oral glucose loading on plasma oxidant:antioxidant balance in normal subjects. Eur. J. Nutr. 2005, 44, 250–254, doi:10.1007/s00394-004-0518-7.
[67]  Jürgens, H.; Haass, W.; Casta?eda, T.R.; Schürmann, A.; Koebnick, C.; Dombrowski, F.; Otto, B.; Nawrocki, A.R.; Scherer, P.E.; Spranger, J.; et al. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes. Res. 2005, 13, 1146–1156, doi:10.1038/oby.2005.136.
[68]  Stavric, B.; Johnson, W.J.; Clayman, S.; Gadd, R.E.; Chartrand, A. Effect of fructose administration on serum urate levels in the uricase inhibited rat. Experientia 1976, 32, 373–374, doi:10.1007/BF01940847.
[69]  Vartanian, L.R.; Schwartz, M.B.; Brownell, K.D. Effects of soft drink consumption on nutrition and health: A systematic review and meta-analysis. Am. J. Public Health 2007, 97, 667–675, doi:10.2105/AJPH.2005.083782.
[70]  Chen, L.; Appel, L.J.; Loria, C.; Lin, P.H.; Champagne, C.M.; Elmer, P.J.; Ard, J.D.; Mitchell, D.; Batch, B.C.; Svetkey, L.P.; et al. Reduction in consumption of sugar-sweetened beverages is associated with weight loss: The PREMIER trial. Am. J. Clin. Nutr. 2009, 89, 1299–1306, doi:10.3945/ajcn.2008.27240.
[71]  Simopoulos, A.P.; Bazan, N.G. Omega-3 Fatty Acids, the Brain and Retina. World Review of Nutrition and Dietetics; Karger: Basel, Switzerland, 2009; Volume 99.
[72]  Spangler, R.; Wittkowski, K.M.; Goddard, N.L.; Avena, N.M.; Hoebel, B.G.; Leibowitz, S.F. Opiate-like effects of sugar on gene expression in reward areas of the rat brain. Brain Res. Mol. Brain Res. 2004, 124, 134–142, doi:10.1016/j.molbrainres.2004.02.013.
[73]  Kelley, A.E.; Bakshi, V.P.; Haber, S.N.; Steininger, T.L.; Will, M.J.; Zhang, M. Opioid modulation of taste hedonics within the ventral striatum. Physiol. Behav. 2002, 76, 365–377, doi:10.1016/S0031-9384(02)00751-5.
[74]  Pelchat, M.L.; Johnson, A.; Chan, R.; Valdez, J.; Ragland, J.D. Images of desire: Food-craving activation during fMRI. Neuroimage 2004, 23, 1486–1493, doi:10.1016/j.neuroimage.2004.08.023.
[75]  Anderzhanova, E.; Covasa, M.; Hajnal, A. Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293, R603–R611, doi:10.1152/ajpregu.00301.2007.
[76]  Teff, K.L.; Elliott, S.S.; Tsch?p, M.; Kieffer, T.J.; Rader, D.; Heiman, M.; Townsend, R.R.; Keim, N.L.; D’Alessio, D.; Havel, P.J. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J. Clin. Endocrinol. Metab. 2004, 89, 2963–2972, doi:10.1210/jc.2003-031855.
[77]  Page, K.A. Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA 2013, 309, 63–70, doi:10.1001/jama.2012.116975.
[78]  Tabas, I.; Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 2011, 13, 184–190, doi:10.1038/ncb0311-184.
[79]  Zhang, X.; Zhang, G.; Zhang, H.; Karin, M.; Bai, H.; Cai, D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008, 135, 61–73, doi:10.1016/j.cell.2008.07.043.
[80]  Purkayastha, S.; Zhang, H.; Zhang, G.; Ahmed, Z.; Wang, Y.; Cai, D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc. Natl. Acad. Sci. USA 2011, 108, 2939–2944.
[81]  Won, J.C.; Jang, P.G.; Namkoong, C.; Koh, E.H.; Kim, S.K.; Park, J.Y.; Lee, K.U.; Kim, M.S. Central administration of an endoplasmic reticulum stress inducer inhibits the anorexigenic effects of leptin and insulin. Obesity 2009, 17, 1861–1865, doi:10.1038/oby.2009.194.
[82]  Denis, R.G.; Arruda, A.P.; Romanatto, T.; Milanski, M.; Coope, A.; Solon, C.; Razolli, D.S.; Velloso, L.A. TNF-alpha transiently induces endoplasmic reticulum stress and an incomplete unfolded protein response in the hypothalamus. Neuroscience 2010, 170, 1035–1044, doi:10.1016/j.neuroscience.2010.08.013.
[83]  Ozcan, L.; Ergin, A.S.; Lu, A.; Chung, J.; Sarkar, S.; Nie, D.; Myers, M.G., Jr.; Ozcan, U. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009, 9, 35–51, doi:10.1016/j.cmet.2008.12.004.
[84]  Myers, M.G.; Cowley, M.A.; Munzberg, H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 2008, 70, 537–556, doi:10.1146/annurev.physiol.70.113006.100707.
[85]  Murphy, K.G.; Bloom, S.R. Gut hormones and the regulation of energy homeostasis. Nature 2006, 444, 854–859, doi:10.1038/nature05484.
[86]  Sandoval, D.; Cota, D.; Seeley, R.J. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu. Rev. Physiol. 2008, 70, 513–535, doi:10.1146/annurev.physiol.70.120806.095256.
[87]  Coll, A.P.; Farooqi, I.S.; O’Rahilly, S. The hormonal control of food intake. Cell 2007, 129, 251–262, doi:10.1016/j.cell.2007.04.001.
[88]  Flier, J.S. Neuroscience. Regulating energy balance: The substrate strikes back. Science 2006, 312, 861–864, doi:10.1126/science.1127971.
[89]  Friedman, J.M. Modern science versus the stigma of obesity. Nat. Med. 2004, 10, 563–569, doi:10.1038/nm0604-563.
[90]  Morton, G.J.; Cummings, D.E.; Baskin, D.G.; Barsh, G.S.; Schwartz, M.W. Central nervous system control of food intake and body weight. Nature 2006, 443, 289–295, doi:10.1038/nature05026.
[91]  Cone, R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 2005, 8, 571–578, doi:10.1038/nn1455.
[92]  Elmquist, J.K.; Coppari, R.; Balthasar, N.; Ichinose, M.; Lowell, B.B. Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J. Comp. Neurol. 2005, 493, 63–71, doi:10.1002/cne.20786.
[93]  Kahn, B.B.; Alquier, T.; Carling, D.; Hardie, D.G. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1, 15–25, doi:10.1016/j.cmet.2004.12.003.
[94]  Pissios, P.; Bradley, R.L.; Maratos-Flier, E. Expanding the scales: The multiple roles of MCH in regulating energy balance and other biological functions. Endocr. Rev. 2006, 27, 606–620, doi:10.1210/er.2006-0021.
[95]  Belgardt, B.F.; Bruning, J.C. CNS leptin and insulin action in the control of energy homeostasis. Ann. N. Y. Acad. Sci. 2012, 1212, 97–113, doi:10.1111/j.1749-6632.2010.05799.x.
[96]  Virtue, S.; Vidal-Puig, A. Nothing Iffy about HIF in the Hypothalamus. PLoS Biol. 2011, 9, e1001116, doi:10.1371/journal.pbio.1001116.
[97]  Meister, B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol. Behav. 2007, 92, 263–271, doi:10.1016/j.physbeh.2007.05.021.
[98]  Yi, C.X.; Habegger, K.M.; Chowen, J.A.; Stern, J.; Tschop, M.H. A role for astrocytes in the central control of metabolism. Neuroendocrinology 2011, 93, 143–149, doi:10.1159/000324888.
[99]  Lam, T.K.; Schwartz, G.J.; Rossetti, L. Hypothalamic sensing of fatty acids. Nat. Neurosci. 2005, 8, 579–584, doi:10.1038/nn1456.
[100]  Cole, A.R.; Astell, A.; Green, C.; Sutherland, C. Molecular connexions between dementia and diabetes. Neurosci. Biobehav. Rev. 2007, 31, 1046–1063, doi:10.1016/j.neubiorev.2007.04.004.
[101]  Shulman, G.I. Cellular mechanism of insulin resistance. J. Clin. Investig. 2000, 106, 171–176, doi:10.1172/JCI10583.
[102]  Agrawal, R.; Gomez-Pinilla, F. “Metabolic syndrome” in the brain: Deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J. Physiol. 2012, 590, 2485–2499, doi:10.1113/jphysiol.2012.230078.
[103]  Gerrits, P.M.; Tsalikian, E. Diabetes and fructose metabolism. Am. J. Clin. Nutr. 1993, 58, 796S–799S.
[104]  Kelley, G.L.; Allan, G.; Azhar, S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology. 2004, 145, 548–555, doi:10.1210/en.2003-1167.
[105]  Pawar, A.; Jump, D.B. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J. Biol. Chem. 2003, 278, 35931–35939, doi:10.1074/jbc.M306238200.
[106]  Schmitz, G.; Ecker, J. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 2008, 47, 147–155, doi:10.1016/j.plipres.2007.12.004.
[107]  Sekiya, M.; Yahagi, N.; Matsuzaka, T.; Najima, Y.; Nakakuki, M.; Nagai, R.; Ishibashi, S.; Osuga, J.; Yamada, N.; Shimano, H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38, 1529–1539.
[108]  Xu, J.; Cho, H.; O’Malley, S.; Park, J.H.; Clarke, S.D. Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and -2 in three distinct stages and by different mechanisms. J. Nutr. 2002, 132, 3333–3339.
[109]  Davidson, M.H. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am. J. Cardiol. 2006, 98, 27i–33i, doi:10.1016/j.amjcard.2005.12.024.
[110]  Appel, L.J.; Miller, E.R., III; Seidler, A.J.; Whelton, P.K. Does supplementation of diet with “fish oil” reduce blood pressure? A meta-analysis of controlled clinical trials. Arch. Intern. Med. 1993, 153, 1429–1438.
[111]  Simopoulos, A.P. Omega-3 fatty acids in inflammation an autoimmune diseases. J. Am. Coll. Nutr. 2002, 21, 495–505, doi:10.1080/07315724.2002.10719248.
[112]  Zelber-Sagi, S.; Nitzan-Kaluski, D.; Goldsmith, R.; Webb, M.; Blendis, L.; Halpern, Z.; Oren, R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J. Hepatol. 2007, 47, 711–717, doi:10.1016/j.jhep.2007.06.020.
[113]  Shapiro, H.; Tehilla, M.; Attal-Singer, J.; Bruck, R.; Luzzatti, R.; Singer, P. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin. Nutr. 2011, 30, 6–19, doi:10.1016/j.clnu.2010.06.001.
[114]  Louchami, K.; Zhang, Y.; Oguzhan, B.; Delporte, C.; Portois, L.; Carpentier, Y.A.; Genten, F.; Danguy, A.; Malaisse, W.J.; Sener, A. Rapid changes in liver lipid composition and pancreatic islet K+ handling and secretory behaviour provoked by the intravenous administration of a medium-chain triglyceride: Fish oil emulsion to long-chain polyunsaturated omega3 fatty acid depleted rats. Int. J. Mol. Med. 2006, 18, 1047–1055.
[115]  Pachikian, B.D.; Neyrinck, A.M.; Cani, P.D.; Portois, L.; Deldicque, L.; de Backer, F.C.; Bindels, L.B.; Sohet, F.M.; Malaisse, W.J.; Francaux, M.; et al. Hepatic steatosis in n-3 fatty acid depleted mice: Focus on metabolic alterations related to tissue fatty acid composition. BMC Physiol. 2008, 8, 21, doi:10.1186/1472-6793-8-21.
[116]  Pachikian, B.D.; Essaghir, A.; Demoulin, J.B.; Neyrinck, A.M.; Catry, E.; de Backer, F.C.; Dejeans, N.; Dewulf, E.M.; Sohet, F.M.; Portois, L.; et al. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: Genomic analysis of cellular targets. PLoS One 2011, 6, e23365, doi:10.1371/journal.pone.0023365.
[117]  Ferre, P.; Foufelle, F. SREBP-1c transcription factor and lipid homeostasis: Clinical perspective. Horm. Res. 2007, 68, 72–82, doi:10.1159/000100426.
[118]  Jump, D.B. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol. 2008, 19, 242–247, doi:10.1097/MOL.0b013e3282ffaf6a.
[119]  Pettinelli, P.; del Pozo, T.; Araya, J.; Rodrigo, R.; Araya, A.V.; Smok, G.; Csendes, A.; Gutierrez, L.; Rojas, J.; Korn, O.; et al. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochim. Biophys. Acta 2009, 1792, 1080–1086.
[120]  Yaqoob, P.; Calder, P.C. Fatty acids and immune function: New insights into mechanisms. Br. J. Nutr. 2007, 98 (Suppl 1.), 41–45.
[121]  Cai, D.; Liu, T. Inflammatory cause of metabolic syndrome via brain stress and NF-κB. Aging 2012, 4, 98–115.
[122]  Simopoulos, A.P. Nutrigenetics/nutrigenomics. Ann. Rev. Public Health 2010, 31, 53–68, doi:10.1146/annurev.publhealth.031809.130844.
[123]  Harris, W.S. Stearidonic acid as a “pro-eicosapentaenoic acid”. Curr. Opin. Lipidol. 2012, 23, 30–34, doi:10.1097/MOL.0b013e32834f0f0c.
[124]  Harris, W.S. Stearidonic acid-enhanced soybean oil: A plant-based source of (n-3) fatty acids for foods. J. Nutr. 2012, 142, 600S–604S, doi:10.3945/jn.111.146613.
[125]  Simopoulos, A.P. Healthy Agriculture, Healthy Nutrition, Healthy People. World Review of Nutrition and Dietetics; Karger: Basel, Switzerland, 2011; Volume 102.
[126]  Simopoulos, A.P.; Faergeman, O.; Bourne, P.G. Action plan for a healthy agriculture, healthy nutrition, healthy people. J. Nutrigenet. Nutrigenomics 2011, 4, 65–68, doi:10.1159/000328438.
[127]  Simopoulos, A.P.; Bourne, P.G.; Faergeman, O. Bellagio report on healthy agriculture, healthy nutrition, healthy people. Nutrients 2013, 5, 411–423, doi:10.3390/nu5020411.
[128]  Yon, M.A.; Mauger, S.L.; Pickavance, L.C. Relationships between dietary macronutrients and adult neurogenesis in the regulation of energy metabolism. Br. J. Nutr. 2013, 109, 1573–1589, doi:10.1017/S000711451200579X.


comments powered by Disqus